Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Steffen Runge is active.

Publication


Featured researches published by Steffen Runge.


Journal of Biological Chemistry | 2008

Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain.

Steffen Runge; Henning Thøgersen; Kjeld Madsen; Jesper Lau; Rainer Rudolph

The glucagon-like peptide-1 receptor (GLP-1R) belongs to Family B1 of the seven-transmembrane G protein-coupled receptors, and its natural agonist ligand is the peptide hormone glucagon-like peptide-1 (GLP-1). GLP-1 is involved in glucose homeostasis, and activation of GLP-1R in the plasma membrane of pancreatic β-cells potentiates glucose-dependent insulin secretion. The N-terminal extracellular domain (nGLP-1R) is an important ligand binding domain that binds GLP-1 and the homologous peptide Exendin-4 with differential affinity. Exendin-4 has a C-terminal extension of nine amino acid residues known as the “Trp cage”, which is absent in GLP-1. The Trp cage was believed to interact with nGLP-1R and thereby explain the superior affinity of Exendin-4. However, the molecular details that govern ligand binding and specificity of nGLP-1R remain undefined. Here we report the crystal structure of human nGLP-1R in complex with the antagonist Exendin-4(9–39) solved by the multiwavelength anomalous dispersion method to 2.2Å resolution. The structure reveals that Exendin-4(9–39) is an amphipathic α-helix forming both hydrophobic and hydrophilic interactions with nGLP-1R. The Trp cage of Exendin-4 is not involved in binding to nGLP-1R. The hydrophobic binding site of nGLP-1R is defined by discontinuous segments including primarily a well defined α-helix in the N terminus of nGLP-1R and a loop between two antiparallel β-strands. The structure provides for the first time detailed molecular insight into ligand binding of the human GLP-1 receptor, an established target for treatment of type 2 diabetes.


Journal of Biological Chemistry | 2000

H19 RNA Binds Four Molecules of Insulin-like Growth Factor II mRNA-binding Protein

Steffen Runge; Finn Cilius Nielsen; Jacob Nielsen; Jens Lykke-Andersen; Ulla M. Wewer; Jan Christiansen

H19 RNA is a major oncofetal 2.5-kilobase untranslated RNA of unknown function. The maternally expressedH19 gene is located 90 kilobase pairs downstream from the paternally expressed insulin-like growth factor II(IGF-II) gene on human chromosome 11 and mouse chromosome 7; and due to their reciprocal imprinting and identical spatiotemporal expression, it is assumed that the two genes are functionally coupled. Here we show that human H19 RNA contains four attachment sites for the oncofetal IGF-II mRNA-binding protein (IMP) with apparentK d values in the 0.4–1.3 nm range. The multiple attachment sites are clustered within a 700-nucleotide segment encoded by exons 4 and 5. This 3′-terminal segment targets H19 RNA to lamellipodia and perinuclear regions in dispersed fibroblasts where IMP is also localized. The results suggest that IMP participates in H19 RNA localization and provides a link between the IGF-II and H19genes at post-transcriptional events during mammalian development.


Journal of Biological Chemistry | 2003

Three Distinct Epitopes on the Extracellular Face of the Glucagon Receptor Determine Specificity for the Glucagon Amino Terminus

Steffen Runge; Christian Gram; Hans Bräuner-Osborne; Kjeld Madsen; Lotte Bjerre Knudsen; Birgitte Schjellerup Wulff


Biochemistry | 2007

Differential Structural Properties of GLP-1 and Exendin-4 Determine Their Relative Affinity for the GLP-1 Receptor N-Terminal Extracellular Domain†

Steffen Runge; Susann Schimmer; Jan Oschmann; Christine Bruun Schiødt; Sanne Møller Knudsen; Claus Jeppesen; Kjeld Madsen; Jesper Lau; Henning Thøgersen; Rainer Rudolph


Archive | 2008

Péptidos derivados con A-B-C-D y sus usos terapéuticos

Jane Spetzler; Lauge Schäffer; Jesper Lau; Thomas Kruse; Patrick William Garibay; Søren Østergaard; Steffen Runge; Henning Thøgersen


Archive | 2008

With ABCD derived peptides and their therapeutic uses

Jane Spetzler; Lauge Schäffer; Jesper Lau; Thomas Kruse; Patrick William Garibay; Søren Østergaard; Steffen Runge; Henning Thøgersen


Archive | 2008

Dérivés de glucagon-like peptide-1 et leur utilisation pharmaceutique

Jane Spetzler; Lauge Schäffer; Jesper Lau; Thomas Kruse; Patrick William Garibay; Steffen Runge; Henning Thøgersen


Archive | 2008

Mit a-b-c-d derivatisierte peptide und ihre therapeutische verwendung

Lauge Schäffer; Søren Østergaard; Henning Thøgersen; Patrick William Garibay; Thomas Kruse; Jesper Lau; Steffen Runge; Jane Spetzler


Archive | 2008

Glucagon-like peptid-1-derivate und ihre pharmazeutische verwendung

Lauge Schäffer; Henning Thøgersen; Patrick William Garibay; Thomas Kruse; Jesper Lau; Steffen Runge; Jane Spetzler


Archive | 2008

Dérivés glp-1 tronqués et utilisations à des fins thérapeutiques de ceux-ci

Jane Spetzler; Lauge Schäffer; Jesper Lau; János Tibor Kodra; Kjeld Madsen; Patrick William Garibay; Jacob Kofoed; Steffen Runge; Henning Thøgersen; Ingrid Pettersson

Collaboration


Dive into the Steffen Runge's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge